Sera Prognostics Inc (SERA)

Sera Prognostics Inc (SERA) is a Medical Devices company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $80.5M; returns 1 day -0.5%, 1 week -1.5%, 1 year -39.4%.

Sera Prognostics Inc. (SERA) is a precision medicine company focused on improving maternal and neonatal health through innovative blood-based biomarker tests. The company's primary revenue driver is the PreTRM® Test, a non-invasive blood test administered during weeks 18-20 of gestational age to predict an individual's risk of spontaneous preterm delivery in asymptomatic singleton pregnancies.

Groups SERA belongs to

• Healthcare
• Precision Medicine
• Women's Health
• Health Diagnostics and Imaging
• Biotechnology
• Healthcare Technology
• Life Sciences
• Commercial Stage
• Neonatal Care

SERA financial model: income statement, cash flow and balance sheet